In conclusion, we demonstrated that DPP4i alleviated the pathogenesis of AMLN diet-induced NASH in a mouse model through the suppression of lipoapoptosis, possibly by regulating hepatic DPP4 expression. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatohepatitis.